HEADER PROTEIN BINDING/INHIBITOR 18-FEB-16 5I86 TITLE CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN CREBBP BOUND TO THE TITLE 2 BENZODIAZEPINONE G02778174 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BROMODOMAIN (UNP RESIDUES 1082-1197); COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BROMODOMAIN INHIBITOR, PROTEIN BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.JAYARAM,F.POY,J.W.SETSER,S.F.BELLON REVDAT 3 27-SEP-23 5I86 1 REMARK REVDAT 2 01-JUN-16 5I86 1 JRNL REVDAT 1 20-APR-16 5I86 0 JRNL AUTH A.M.TAYLOR,A.COTE,M.C.HEWITT,R.PASTOR,Y.LEBLANC, JRNL AUTH 2 C.G.NASVESCHUK,F.A.ROMERO,T.D.CRAWFORD,N.CANTONE,H.JAYARAM, JRNL AUTH 3 J.SETSER,J.MURRAY,M.H.BERESINI,G.DE LEON BOENIG,Z.CHEN, JRNL AUTH 4 A.R.CONERY,R.T.CUMMINGS,L.A.DAKIN,E.M.FLYNN,O.W.HUANG, JRNL AUTH 5 S.KAUFMAN,P.J.KELLER,J.R.KIEFER,T.LAI,Y.LI,J.LIAO,W.LIU, JRNL AUTH 6 H.LU,E.PARDO,V.TSUI,J.WANG,Y.WANG,Z.XU,F.YAN,D.YU, JRNL AUTH 7 L.ZAWADZKE,X.ZHU,X.ZHU,R.J.SIMS,A.G.COCHRAN,S.BELLON, JRNL AUTH 8 J.E.AUDIA,S.MAGNUSON,B.K.ALBRECHT JRNL TITL FRAGMENT-BASED DISCOVERY OF A SELECTIVE AND CELL-ACTIVE JRNL TITL 2 BENZODIAZEPINONE CBP/EP300 BROMODOMAIN INHIBITOR (CPI-637). JRNL REF ACS MED.CHEM.LETT. V. 7 531 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 27190605 JRNL DOI 10.1021/ACSMEDCHEMLETT.6B00075 REMARK 2 REMARK 2 RESOLUTION. 1.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0069 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 103515 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.140 REMARK 3 R VALUE (WORKING SET) : 0.139 REMARK 3 FREE R VALUE : 0.161 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5440 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7198 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.47 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE SET COUNT : 388 REMARK 3 BIN FREE R VALUE : 0.2390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1933 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 57 REMARK 3 SOLVENT ATOMS : 385 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.14000 REMARK 3 B22 (A**2) : 0.37000 REMARK 3 B33 (A**2) : -0.41000 REMARK 3 B12 (A**2) : 0.22000 REMARK 3 B13 (A**2) : -0.23000 REMARK 3 B23 (A**2) : 0.27000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.027 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.027 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.019 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.828 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.977 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.973 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2154 ; 0.010 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2033 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2930 ; 1.583 ; 2.002 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4695 ; 0.762 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 246 ; 5.752 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 110 ;41.593 ;24.636 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 382 ;12.259 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;18.922 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 297 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2437 ; 0.017 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 509 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 965 ; 1.475 ; 1.179 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 963 ; 1.387 ; 1.176 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1215 ; 1.585 ; 1.774 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 4187 ; 6.583 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 67 ;23.645 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 4440 ;11.453 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5I86 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000218452. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 108956 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3DWY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M POTASSIUM THIOCYANATE, 0.1 M BIS REMARK 280 -TRIS, PH 5.5, 5% V/V ETHYLENE GLYCOL, 23% PEG3350, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1080 REMARK 465 SER A 1081 REMARK 465 GLY A 1197 REMARK 465 GLY B 1080 REMARK 465 SER B 1081 REMARK 465 LYS B 1082 REMARK 465 GLY B 1197 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1360 O HOH A 1372 1.87 REMARK 500 NH2 ARG B 1091 O HOH B 1301 1.99 REMARK 500 O HOH B 1441 O HOH B 1455 2.07 REMARK 500 O HOH B 1332 O HOH B 1460 2.07 REMARK 500 O HOH B 1476 O HOH B 1478 2.15 REMARK 500 O HOH A 1466 O HOH A 1472 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B1091 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLN A1104 10.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1494 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH A1495 DISTANCE = 7.68 ANGSTROMS REMARK 525 HOH A1496 DISTANCE = 7.79 ANGSTROMS REMARK 525 HOH B1489 DISTANCE = 6.99 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SCN A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 69A A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 69A B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues EDO A 1201 and EDO B REMARK 800 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues EDO A 1201 and EDO B REMARK 800 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues EDO A 1201 and EDO B REMARK 800 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5I83 RELATED DB: PDB REMARK 900 RELATED ID: 5I89 RELATED DB: PDB DBREF 5I86 A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 5I86 B 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQADV 5I86 GLY A 1080 UNP Q92793 EXPRESSION TAG SEQADV 5I86 SER A 1081 UNP Q92793 EXPRESSION TAG SEQADV 5I86 GLY B 1080 UNP Q92793 EXPRESSION TAG SEQADV 5I86 SER B 1081 UNP Q92793 EXPRESSION TAG SEQRES 1 A 118 GLY SER LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN SEQRES 2 A 118 ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP SEQRES 3 A 118 PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN SEQRES 4 A 118 LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN SEQRES 5 A 118 PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR SEQRES 6 A 118 GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL SEQRES 7 A 118 TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS SEQRES 8 A 118 THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU SEQRES 9 A 118 VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU SEQRES 10 A 118 GLY SEQRES 1 B 118 GLY SER LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN SEQRES 2 B 118 ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP SEQRES 3 B 118 PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN SEQRES 4 B 118 LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN SEQRES 5 B 118 PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR SEQRES 6 B 118 GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL SEQRES 7 B 118 TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS SEQRES 8 B 118 THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU SEQRES 9 B 118 VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU SEQRES 10 B 118 GLY HET EDO A1201 4 HET SCN A1202 3 HET 69A A1203 23 HET EDO B1201 4 HET 69A B1202 23 HETNAM EDO 1,2-ETHANEDIOL HETNAM SCN THIOCYANATE ION HETNAM 69A (4R)-N-BENZYL-4-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-1,5- HETNAM 2 69A BENZODIAZEPINE-6-CARBOXAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 2(C2 H6 O2) FORMUL 4 SCN C N S 1- FORMUL 5 69A 2(C18 H19 N3 O2) FORMUL 8 HOH *385(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1116 GLY A 1121 1 6 HELIX 4 AA4 ASP A 1124 VAL A 1129 1 6 HELIX 5 AA5 ASP A 1134 THR A 1144 1 11 HELIX 6 AA6 GLU A 1149 ASN A 1168 1 20 HELIX 7 AA7 SER A 1172 LEU A 1196 1 25 HELIX 8 AA8 LYS B 1086 ARG B 1103 1 18 HELIX 9 AA9 SER B 1108 ARG B 1112 5 5 HELIX 10 AB1 ASP B 1116 GLY B 1121 1 6 HELIX 11 AB2 ASP B 1124 VAL B 1129 1 6 HELIX 12 AB3 ASP B 1134 THR B 1144 1 11 HELIX 13 AB4 GLU B 1149 ASN B 1168 1 20 HELIX 14 AB5 SER B 1172 LEU B 1196 1 25 CISPEP 1 ASP A 1105 PRO A 1106 0 15.84 CISPEP 2 ASP B 1105 PRO B 1106 0 17.32 SITE 1 AC1 6 LEU A1098 TYR A1102 LEU A1135 SER A1136 SITE 2 AC1 6 HOH A1314 HOH A1417 SITE 1 AC2 8 PRO A1110 LEU A1120 TYR A1125 ASN A1168 SITE 2 AC2 8 ARG A1173 VAL A1174 HOH A1309 HOH A1350 SITE 1 AC3 9 PRO B1110 VAL B1115 LEU B1120 TYR B1125 SITE 2 AC3 9 ASN B1168 ARG B1173 VAL B1174 HOH B1306 SITE 3 AC3 9 HOH B1316 SITE 1 AC4 6 ASN A1168 SER A1172 ARG A1173 VAL A1174 SITE 2 AC4 6 HOH A1353 GLU B1186 SITE 1 AC5 6 ASN A1168 SER A1172 ARG A1173 VAL A1174 SITE 2 AC5 6 HOH A1353 GLU B1186 SITE 1 AC6 6 ASN A1168 SER A1172 ARG A1173 VAL A1174 SITE 2 AC6 6 HOH A1353 GLU B1186 CRYST1 33.993 42.002 49.800 96.77 109.70 99.39 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029418 0.004864 0.011642 0.00000 SCALE2 0.000000 0.024132 0.004573 0.00000 SCALE3 0.000000 0.000000 0.021708 0.00000